Shopping Cart
- Remove All
 
Your shopping cart is currently empty
Laromustine (VNP40101M) is a sulfonyl hydrolytic alkylating prodrug used in cancer therapy with significant anticancer activity.
Inhibiting thioredoxin reductase can be used to study acute myeloid leukemia.

| Pack Size | Price | Availability | Quantity | 
|---|---|---|---|
| 1 mg | $293 | In Stock | |
| 5 mg | $722 | In Stock | |
| 10 mg | $987 | In Stock | |
| 25 mg | $1,520 | In Stock | |
| 50 mg | $1,980 | In Stock | 
| Description | Laromustine (VNP40101M) is a sulfonyl hydrolytic alkylating prodrug used in cancer therapy with significant anticancer activity. Inhibiting thioredoxin reductase can be used to study acute myeloid leukemia.  | 
| Targets&IC50 |  CYP2B6:125 mM (Ki), CYP3A4/5:297 mM (Ki), CYP2C19:349 mM (ki)  | 
| In vitro | Laromustine caused direct inhibition of CYP2B6 and CYP3A4/5 as well as of CYP2C19. CYP2B6 K(i)=125 mM, CYP3A4/5 K(i)=297 mM, and CYP2C19 K(i)=349 mM and were greater than the average clinical plasma C(max) of Laromustine (C(max)=25 mM). [1]  | 
| Synonyms | VNP40101M, VNP 40101M | 
| Molecular Weight | 307.78 | 
| Formula | C6H14ClN3O5S2 | 
| Cas No. | 173424-77-6 | 
| Smiles | O=C(NC)N(N(CCCl)S(=O)(=O)C)S(=O)(=O)C | 
| Color | White | 
| Appearance | Solid | 
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | 

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.